From Milan to Las Vegas, from Italy to the USA. RIC3D is one of the innovative startups chosen by ICE-ITA – as part of its promotional activities in support of internationalization – to participate in the upcoming CES 2022, which will be held from 5th to 8th of January, 2022.

RIC3D is getting ready to fly to Nevada to participate in the 55th edition of the Consumer Electronic Show (CES) in Las Vegas, the largest hi-tech trade show in the world. As a showcase for all the major and most innovative technologies, innovations and consumer electronics, CES is the world’s most influential event for startups, offering them the opportunity to launch future products, forge new partnerships and meet new investors.

But it goes further than that. As can be easily seen from the statements of Gary Shapiro – president and CEO of the Consumer Technology Association that organizes the CES in Las Vegas – the world not only of electronics and digital, but also of Artificial Intelligence (AI), 3D printing and Virtual Reality has come to embrace many sectors that were once considered traditional: one above all, the medical sector, which has “transformed” into Med-Tech once it has experienced the revolutionary integration of technology.

In light of this, CES 2022 will be a unique opportunity for RIC3D to showcase its ROG (Real Organ Generation) project to the U.S. market. It involves the development of a software application that enables virtual heart surgery simulation; in particular, through a patented method of generating 3D images of pathological tissues, the software is able to digitize the organ in its real state and size. Thus, leveraging Virtual Reality and AI technologies, ROG can localize the exact location of pathologies and allows its users to interact with the organ and perform virtual surgical simulation activities.


As a highly MedTech-oriented innovative startup, RIC3D has chosen to contribute to the future of healthcare with its ROG project, aiming to respond to the high demand for advanced technology capable of intercepting the existing gap in healthcare and medical solutions – in an extremely delicate field such as cardiac surgery. RIC3D’s mission, indeed, is to strengthen the confidence of the healthcare sector in new technologies, thus accelerating the research, development and adoption of these technologies, in order to provide more and better care to patients in need.

RIC3D is a young company with a glocal vocation that, since its birth in 2018, has started paths of internationalization, gaining increasingly large market shares. With the ambition to become a company-leader in the healthcare sector, RIC3D has been able to take advantage of the wide network offered by the Techinnova incubator to start profitable collaborations on a local and European scale. But after having presented its R&D projects at the major trade fairs in the Middle East (Gitex 2020 in Dubai and Arab Health 2021), the time has come for RIC3D to enter the most dynamic of foreign markets: the American market.

Participating in CES 2022, therefore, is part of a process of potential collaboration with a geographical area that is extremely cutting-edge, highly competitive and certainly attractive to entrepreneurs in terms of technological development, innovation and economic context.


RIC3D’s presence will be located within Eureka Park (the pavilion dedicated to innovative startups) – Venue: Sands Convention Center, Hall G; booth: 62724.